Palvella Therapeutics (PVLA) Share-based Compensation Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 208.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 208.59% |
| Dec 31, 2025 | 677.61% |
| Sep 30, 2025 | 799.50% |
| Jun 30, 2025 | 560.37% |
| Mar 31, 2025 | 649.32% |
| Dec 31, 2024 | 111.68% |
| Sep 30, 2024 | -79.40% |
| Jun 30, 2024 | -79.29% |
| Mar 31, 2024 | -83.48% |
| Dec 31, 2023 | -341.83% |
| Sep 30, 2023 | -0.82% |
| Jun 30, 2023 | -19.45% |
| Mar 31, 2023 | -24.96% |
| Dec 31, 2022 | -28.11% |
| Sep 30, 2022 | -28.91% |
| Jun 30, 2022 | -1.89% |
| Mar 31, 2022 | -1.75% |
| Dec 31, 2021 | 12.44% |
| Sep 30, 2021 | -1.86% |
| Jun 30, 2021 | 7.19% |
| Mar 31, 2021 | -6.55% |
| Dec 31, 2020 | 5.39% |
| Sep 30, 2020 | -8.04% |
| Jun 30, 2020 | -14.81% |
| Mar 31, 2020 | -0.54% |
| Dec 31, 2019 | -12.83% |
| Sep 30, 2019 | 15.88% |
| Jun 30, 2019 | 7.48% |
| Mar 31, 2019 | 28.49% |
| Dec 31, 2018 | 17.90% |
| Sep 30, 2018 | 101.55% |
| Jun 30, 2018 | 141.30% |
| Mar 31, 2018 | 33.51% |
| Dec 31, 2017 | 126.47% |
| Sep 30, 2017 | 45.69% |
| Jun 30, 2017 | -8.49% |
| Mar 31, 2017 | 104.14% |
| Dec 31, 2016 | 227.04% |
| Sep 30, 2016 | 32.07% |
| Jun 30, 2016 | 128.27% |
| Mar 31, 2016 | 18.43% |